Retina Consultants of Seattle, PC
Retina Consultants of Seattle, PC was paid $1.49M by Medicaid between Jan 2018 and Dec 2024, across 19 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 53% of everything it billed.
33Billing provider infoRETINA CONSULTANTS OF SEATTLE, PC
SEATTLE, WA 98133
SEATTLE, WA 98133
33aNPI1467566828assigned 08/19/2006
33bProvider typeSpecialist
28Total paid$1.49M
24GClaims38,082
24DCodes billed19
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Washington
Rank by total paid#9 of 96
Median peer was paid$49K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,764 | $122K | |
| 2019 | 5,291 | $118K | |
| 2020 | 3,883 | $201K | |
| 2021 | 7,064 | $390K | |
| 2022 | 5,543 | $234K | |
| 2023 | 5,416 | $199K | |
| 2024incomplete | 5,121 | $231K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 53% | 1,001 | 783 | $789K |
| 67028 | Intravitreal injection of a pharmacologic agent | 12% | 6,549 | 5,147 | $181K |
| 92134 | 11% | 12,444 | 11,139 | $165K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 11% | 6,296 | 5,469 | $158K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5.8% | 2,127 | 1,990 | $87K |
| 92250 | 2.4% | 2,224 | 2,081 | $36K | |
| 92226 | 1.8% | 3,454 | 1,835 | $27K | |
| 92202 | 1.0% | 2,817 | 2,579 | $15K | |
| J2778 | Injection, ranibizumab, 0.1 mg | <1% | 22 | 13 | $11K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 227 | 172 | $7K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 97 | 92 | $6K |
| 92020 | <1% | 319 | 289 | $3K |
7 more codes
| 92225 | <1% | 236 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 49 | $2K |
| 92235 | <1% | 42 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 28 | $1K |
| 92201 | <1% | 94 | $990.44 | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 14 | $976.53 |
| 99072 | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTOLMEIER, KRIS (ADMINISTRATOR)